Shadman M, Munir T, Ma S, Lasica M, et al. Zanubrutinib and Venetoclax for Patients With Treatment-Naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/TP53 Mutation: SEQUOIA Arm D Results. J Clin Oncol 2025 May 31:JCO2500758. doi: 10.1200/JCO-25-00758.
PMID: 40448577